Kala Bio KALA
NASDAQ KALA
$0.82 -0.02 (-2.39%)
As of: Aug 21, 2026 · 3:58 PM EDT

Kala Bio (KALA) Profit After Tax (2016 - 2026)

Kala Bio (KALA) posted Profit After Tax of -$1.6 million for Q1 2026, down 336.3% sequentially from $686000.0 in Q4 2025, and up 81.88% YoY from -$891236.2 in Q1 2025.

Kala Bio (KALA) Profit After Tax (2016 - 2026) Analysis & Trends

Kala Bio has reported Profit After Tax for 11 years, with the latest figure at -$1.6 million in Q1 2026.

  • Quarterly Profit After Tax rose 81.88% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.7 million (up 44.87% YoY) and the FY2025 annual result came in at -$27.0 million, up 29.94% from the prior year.
  • Profit After Tax retreated to -$1.6 million in Q1 2026 per KALA's latest filing, from $686000.0 in the prior quarter.
  • Over five years, Profit After Tax peaked at $29.1 million in Q3 2022 and troughed at -$32.9 million in Q1 2022.
  • A 5-year average of -$9.1 million and a median of -$9.0 million in 2024 frame the typical range for Profit After Tax.
  • The sharpest annual moves came in 2022 and 2023: Profit After Tax soared 203.36% in 2022, then plunged 129.94% in 2023.
  • Over 5 years, Profit After Tax stood at -$12.8 million in 2022, then jumped by 32.83% to -$8.6 million in 2023, then climbed by 5.24% to -$8.2 million in 2024, then jumped by 108.39% to $686000.0 in 2025, then sank by 336.3% to -$1.6 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$1.6 million, $686000.0, and -$7.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Kala Bio 9.89 Mn 9.89 Mn - -1.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.62 Mn
Dec 31, 2025 686,000.00
Sep 30, 2025 -7.56 Mn
Jun 30, 2025 -11.16 Mn
Mar 31, 2025 -8.95 Mn
Dec 31, 2024 -8.18 Mn
Sep 30, 2024 -8.95 Mn
Jun 30, 2024 -9.58 Mn
Mar 31, 2024 -11.81 Mn
Dec 31, 2023 -8.63 Mn
Sep 30, 2023 -8.70 Mn
Jun 30, 2023 -10.41 Mn
Mar 31, 2023 -14.46 Mn
Dec 31, 2022 -12.84 Mn
Sep 30, 2022 29.07 Mn
Jun 30, 2022 -28.11 Mn
Mar 31, 2022 -32.94 Mn
Dec 31, 2021 -47.57 Mn
Sep 30, 2021 -28.13 Mn
Jun 30, 2021 -36.50 Mn